Codes / ICD10CM / G21.0

G21.0 Malignant neuroleptic syndrome

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neuroleptic syndrome

Summary

Malignant neuroleptic syndrome is a rare but serious reaction to antipsychotic medications, characterized by muscle rigidity, fever, and autonomic dysfunction. It is a life-threatening condition that requires immediate medical intervention.

Causes

This syndrome is primarily caused by the use of neuroleptic (antipsychotic) drugs, which interfere with dopamine transmission in the brain. Other medications, such as antiemetics or certain antidepressants, may also trigger it in susceptible individuals.

Risk Factors

  • High doses or rapid dose increases of neuroleptics.
  • Use of high-potency antipsychotics.
  • Dehydration or electrolyte imbalances.
  • Pre-existing neurological conditions.
  • Younger age or male gender.

Symptoms

  • Severe muscle rigidity.
  • High fever.
  • Altered mental status (confusion, agitation).
  • Autonomic instability (e.g., rapid heart rate, blood pressure fluctuations).
  • Excessive sweating.
  • Elevated creatine kinase (CK) levels.

Diagnosis

Diagnosis is based on clinical presentation, medication history, and exclusion of other conditions. Key criteria include hyperthermia, rigidity, and autonomic dysfunction, often supported by elevated CK and leukocytosis.

Treatment Options

  • Immediate discontinuation of the offending medication.
  • Supportive care (cooling, hydration, electrolyte management).
  • Use of medications like dantrolene or bromocriptine to reduce muscle rigidity and dopamine blockade.
  • Monitoring in an intensive care setting.

Prognosis and Follow-Up

With prompt treatment, most patients recover, but mortality can occur due to complications like renal failure or respiratory distress. Follow-up includes monitoring for recurrence and adjusting future medication regimens.

Complications

  • Rhabdomyolysis (muscle breakdown).
  • Acute kidney injury.
  • Respiratory failure.
  • Neurological damage from prolonged hyperthermia.

Lifestyle & Prevention

  • Avoid abrupt changes in neuroleptic dosages.
  • Stay hydrated and maintain electrolyte balance.
  • Inform healthcare providers of all medications, including over-the-counter drugs.
  • Regular monitoring during neuroleptic therapy.

When to Seek Professional Help

Seek immediate medical attention if experiencing muscle stiffness, high fever, confusion, or autonomic symptoms (e.g., rapid heart rate) after starting or adjusting neuroleptic medications.

Tips for Medical Coders

Document the specific neuroleptic agent, onset timing, and clinical findings (e.g., fever, rigidity, elevated CK) to support coding. Ensure the diagnosis aligns with the clinical criteria for malignant neuroleptic syndrome and differentiate it from other drug-induced reactions.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

G21.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.